BIT 0.00% 2.2¢ biotron limited

$10 Billion Deal, page-12792

  1. 658 Posts.
    lightbulb Created with Sketch. 121
    I think there's some merit in that. I think its also fairly generic. How many are at equivalent stage and have a 20yr track record? Prior engagement from potential suitors, etc

    I wonder if it reflects on our SP. As you point out we are at precipice of delivery - stated as this quarter!

    M&A is increasing in US btw.

    Please click this URL to join. https://us02web.zoom.us/w/84146359586?tk=UeR18c1y7jXpFHSz4PyQJLNqbBESRJhjMrZcoBAi_nQ.DQYAAAATl4ONIhZwVTRLTUg2Y1EwR1ExMXdaSUh4NG9BAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA&uuid=WN_bJZ0mkCnTT6kOvAOKlKrWA

    Description: In biotech, a recovery is already well underway. Expected interest rate cuts and improving valuations across public and private markets are creating a compelling environment for deals, entrances, exits, and trades to take shape.




 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.